Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Herman Ellman
Pharmacokinetic Evaluation of Once-Daily Topical 4% Minocycline Foam in Adult and Pediatric Subjects With Moderate-To-Severe Acne in Two Phase 1 Studies
SKIN The Journal of Cutaneous Medicine
Pharmacokinetic Evaluation of Once-Daily Topical 4% Minocycline Foam in Adult and Pediatric Subjects With Moderate-To-Severe Acne in Two Phase 1 Studies
SKIN The Journal of Cutaneous Medicine
The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies
SKIN The Journal of Cutaneous Medicine
Related publications
Pharmacokinetics of Minocycline Foam FMX103 in Subjects With Moderate-To-Severe Facial Papulopustular Rosacea Under Maximum-Use Conditions: Results of a Phase 1 Study
SKIN The Journal of Cutaneous Medicine
Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study
Thorax
Pulmonary
Respiratory Medicine
252 Prevalence of Moderate to Severe Acne in Transgender Adults
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
622 a Proof of Concept Clinical Study to Test the Efficacy and Safety of VB1953 in Moderate to Severe Acne Subjects
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Evaluation of Pharmacokinetic Interaction Between PA-824 and Midazolam in Healthy Adult Subjects
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Relationships Between Clinical Scales and Binge Eating Days in Adults With Moderate to Severe Binge Eating Disorder in Two Phase III Studies
Neuropsychiatric Disease and Treatment
